|
Vendevia Group |
|
Biomedical Venture Development |
|
About Vendevia Group |
|
Vendevia Group was founded by Dr. Boris Reznik in 2002, when after decades of successful serial entrepreneurship, he decided to create an industrialized approach to development of technology ventures. Vendevia Group started with putting together the processes and infrastructure of Venture Development.
These efforts evolved over the years as we were developing the initial portfolio companies and currently Vendevia Group infrastructure covers all areas of expertise and capabilities necessary for successful biomedical venture development and value optimization:
R&D, and commercialization expertise; Wet labs and in-vivo testing facilities; Translational clinical development CRO capabilities; Finance, accounting and administration; In house legal and IP professionals; Business development and investment banking services.
Vendevia Group is headquartered in Miami, Florida and additionally maintains offices in San Diego, California; Zurich, Switzerland; and Moscow, Russia.
|
